You are using an outdated browser. Please upgrade your browser to improve your experience.


Ligand Summary
An anti-IgE, recombinant, humanized monoclonal antibody which specifically binds to the C epsilon3 domain of IMMUNOGLOBULIN E, the site of high-affinity IgE receptor binding. It inhibits the binding of IgE to MAST CELLS and BASOPHILS to reduce the severity of the allergic response and is used in the management of persistent allergic ASTHMA.
Synonyms & Links
DrugCentral: 4972
LyCHI:  omalizumab

Target Activities